Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Oral Oncol. 2014 Jun 3;50(8):746–752. doi: 10.1016/j.oraloncology.2014.05.003

Table 2.

Clinical Characteristics of Cases and Controls

Cases (n=12) Controls (n=26) p-value
Gender 0.90
 Male 9 (75%) 19 (73%)
 Female 3 (25%) 7 (27%)
Age at XRT
 Mean 52.3 (0%) 57 (0%)
 Median 53 (0%) 55 (0%)
 Range 32–53 33–55
T Stage 0.001*
 T1 0 (0%) 13 (50%)
 T2 5 (42%) 9 (35%)
 T3 6 (50%) 4 (15%)
 T4 1 (8%) 0 (0%)
N Stage 0.11
 N0 1 (8%) 0 (0%)
 N1 1 (8%) 0 (0%)
 N2A 1 (8%) 0 (0%)
 N2B 6 (50%) 17 (65%)
 N2C 2 (17%) 8 (31%)
 N3 1 (8%) 1 (4%)
Subsite 0.16
 Base of Tongue 5 (42%) 18 (69%)
 Tonsil 7 (58%) 8 (31%)
Cigarettes at Diagnosis 0.91
 Never (<100 cig/lifetime) 6 (50%) 14 (54%)
 Former (quit > 1 year) 4 (33%) 9 (34%)
 Current 2 (17%) 3 (12%)
Race 0.39
 White 10 (83%) 24 (92%)
 Black 1 (8%) 0 (0%)
 Latin American 1 (8%) 1 (4%)
 Asian 0 (0%) 1 (4%)
Accelerated Fractionation 0.06
 Single 4 (33%) 17 (65%)
 Accelerated 8 (67%) 9 (35%)
Concurrent 0.07
 No 5 (42%) 19 (73%)
 Yes 7 (58%) 7 (27%)